Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 7

1.

FGF19 exhibits neuroprotective effects on adult mammalian photoreceptors in vitro.

Siffroi-Fernandez S, Felder-Schmittbuhl MP, Khanna H, Swaroop A, Hicks D.

Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1696-704. doi: 10.1167/iovs.07-1272.

PMID:
18385093
2.

FGF19 and cancer.

Lin BC, Desnoyers LR.

Adv Exp Med Biol. 2012;728:183-94. doi: 10.1007/978-1-4614-0887-1_12. Review.

PMID:
22396170
3.

Neuritogenic and neuroprotective properties of peptide agonists of the fibroblast growth factor receptor.

Li S, Bock E, Berezin V.

Int J Mol Sci. 2010 May 26;11(6):2291-305. doi: 10.3390/ijms11062291. Review.

4.

Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy.

Giacomini A, Chiodelli P, Matarazzo S, Rusnati M, Presta M, Ronca R.

Pharmacol Res. 2016 Mar 22;107:172-185. doi: 10.1016/j.phrs.2016.03.024. [Epub ahead of print] Review.

PMID:
27013279
5.

Targeting fibroblast growth factor 19 in liver disease: a potential biomarker and therapeutic target.

Liu WY, Xie DM, Zhu GQ, Huang GQ, Lin YQ, Wang LR, Shi KQ, Hu B, Braddock M, Chen YP, Zheng MH.

Expert Opin Ther Targets. 2015 May;19(5):675-85. doi: 10.1517/14728222.2014.997711. Epub 2014 Dec 30. Review.

PMID:
25547779
6.

Homeostatic regulation of photoreceptor cell integrity: significance of the potent mediator neuroprotectin D1 biosynthesized from docosahexaenoic acid: the Proctor Lecture.

Bazan NG.

Invest Ophthalmol Vis Sci. 2007 Nov;48(11):4866-81; biography 4864-5. Review. No abstract available.

PMID:
17962433
7.

Modulation of metabolic syndrome by fibroblast growth factor 19 (FGF19)?

Strack AM, Myers RW.

Endocrinology. 2004 Jun;145(6):2591-3. Review. No abstract available.

PMID:
15140837
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk